Global Acne Treatment Market Forecast till 2027

$4,450$6,250

The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027.

Clear

Description

Global Acne Treatment Market: Information by Acne Type (Moderate, Mild, Moderate to Severe), by Treatment (Medication, Therapeutic Devices), by Drug Type (OTC, Prescription), by Route of Administration (Topical, Oral, Injectable), by End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027

Acne Treatment Market Overview

The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.

Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis

Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.

Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 18

1.1 OVERVIEW 18

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 21

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 HIGH GLOBAL ACNE PREVALENCE 30

4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30

4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30

4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31

4.3 RESTRAINTS 32

4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32

4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33

4.5 TRENDS 33

4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33

4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34

5 MARKET FACTOR ANALYSIS 35

5.1 VALUE CHAIN ANALYSIS 35

5.1.1 R&D AND DESIGNING 36

5.1.2 MANUFACTURING 36

5.1.3 DISTRIBUTION 36

5.1.4 MARKETING & SALES 36

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 38

5.2.4 THREAT OF SUBSTITUTES 38

5.2.5 INTENSITY OF RIVALRY 38

5.3 IMPACT OF COVID-19 38

5.4 PESTEL ANALYSIS 40

6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41

6.1 OVERVIEW 41

6.2 MODERATE ACNE 42

6.3 MILD ACNE 43

6.4 MODERATE TO SEVERE ACNE 43

7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44

7.1 OVERVIEW 44

7.2 MEDICATION 45

7.3 THERAPEUTIC DEVICES 46

8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48

8.1 OVERVIEW 48

8.2 OTC 49

8.3 PRESCRIPTION 49

9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50

9.1 OVERVIEW 50

9.2 TOPICAL 51

9.3 ORAL 51

9.4 INJECTABLE 52

10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53

10.1 OVERVIEW 53

10.2 HOSPITALS & CLINICS 54

10.3 SPECIALTY CENTERS 54

11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55

11.1 OVERVIEW 55

11.2 AMERICAS 56

11.2.1 NORTH AMERICA 59

11.2.1.1 US 62

11.2.1.2 CANADA 65

11.2.2 LATIN AMERICA 67

11.3 EUROPE 70

11.3.1 WESTERN EUROPE 73

11.3.1.1 GERMANY 76

11.3.1.2 FRANCE 79

11.3.1.3 UK 80

11.3.1.4 ITALY 82

11.3.1.5 SPAIN 84

11.3.1.6 REST OF WESTERN EUROPE 86

11.3.2 EASTERN EUROPE 89

11.4 ASIA-PACIFIC 92

11.4.1 CHINA 95

11.4.2 JAPAN 98

11.4.3 INDIA 100

11.4.4 AUSTRALIA 102

11.4.5 SOUTH KOREA 104

11.4.6 REST OF ASIA-PACIFIC 106

11.5 MIDDLE EAST & AFRICA 109

11.5.1 MIDDLE EAST 112

11.5.2 AFRICA 115

12 COMPETITIVE LANDSCAPE 117

12.1 OVERVIEW 117

12.2 LEADING MARKET PLAYERS 117

12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118

12.4 COMPETITIVE BENCHMARKING 119

12.4.1 APPROVAL 120

12.4.2 PRODUCT LAUNCH 120

12.4.3 EXPANSION & ACQUISITION 121

12.4.4 AGREEMENT 121

12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122

13 COMPANY PROFILES 126

13.1 GLAXOSMITHKLINE PLC 126

13.1.1 COMPANY OVERVIEW 126

13.1.2 FINANCIAL OVERVIEW 127

13.1.3 PRODUCTS/SERVICES OFFERED 127

13.1.4 KEY DEVELOPMENTS 128

13.1.5 SWOT ANALYSIS 128

13.1.6 KEY STRATEGIES 128

13.2 ALMIRALL, S.A. 129

13.2.1 COMPANY OVERVIEW 129

13.2.2 FINANCIAL OVERVIEW 129

13.2.3 PRODUCTS/SERVICES OFFERED 130

13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130

13.2.5 SWOT ANALYSIS 131

13.2.6 KEY STRATEGIES 131

13.3 GALDERMA LABORATORIES, L.P. 132

13.3.1 COMPANY OVERVIEW 132

13.3.2 FINANCIAL OVERVIEW 132

13.3.3 PRODUCTS/SERVICES OFFERED 132

13.3.4 KEY DEVELOPMENTS 133

13.3.5 SWOT ANALYSIS 133

13.3.6 KEY STRATEGIES 133

13.4 F. HOFFMAN LA ROCHE LTD 134

13.4.1 COMPANY OVERVIEW 134

13.4.2 FINANCIAL OVERVIEW 135

13.4.3 PRODUCTS/SERVICES OFFERED 135

13.4.4 KEY DEVELOPMENTS 135

13.4.5 SWOT ANALYSIS 136

13.4.6 KEY STRATEGIES 136

13.5 BAUSCH HEALTH COMPANIES INC. 137

13.5.1 COMPANY OVERVIEW 137

13.5.2 FINANCIAL OVERVIEW 137

13.5.3 PRODUCTS/SERVICES OFFERED 138

13.5.4 KEY DEVELOPMENTS 138

13.5.5 SWOT ANALYSIS 139

13.5.6 KEY STRATEGIES 139

13.6 LEO PHARMA A/S 140

13.6.1 COMPANY OVERVIEW 140

13.6.2 FINANCIAL OVERVIEW 140

13.6.3 PRODUCTS/SERVICES OFFERED 141

13.6.4 KEY DEVELOPMENTS 141

13.6.5 SWOT ANALYSIS 141

13.6.6 KEY STRATEGIES 142

13.7 JOHNSON & JOHNSON SERVICES INC. 143

13.7.1 COMPANY OVERVIEW 143

13.7.2 FINANCIAL OVERVIEW 143

13.7.3 PRODUCTS/SERVICES OFFERED 144

13.7.4 KEY DEVELOPMENTS 144

13.7.5 SWOT ANALYSIS 144

13.7.6 KEY STRATEGIES 145

13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146

13.8.1 COMPANY OVERVIEW 146

13.8.2 FINANCIAL OVERVIEW 146

13.8.3 PRODUCTS/SERVICES OFFERED 147

13.8.4 KEY DEVELOPMENTS 147

13.8.5 SWOT ANALYSIS 147

13.8.6 KEY STRATEGIES 148

13.9 CANDELA CORPORATION 149

13.9.1 COMPANY OVERVIEW 149

13.9.2 FINANCIAL OVERVIEW 149

13.9.3 PRODUCTS/SERVICES OFFERED 149

13.9.4 KEY DEVELOPMENTS 149

13.9.5 SWOT ANALYSIS 150

13.9.6 KEY STRATEGIES 150

13.10 VYNE THERAPEUTICS INC. 151

13.10.1 COMPANY OVERVIEW 151

13.10.2 FINANCIAL OVERVIEW 151

13.10.3 PRODUCTS/SERVICES OFFERED 151

13.10.4 KEY DEVELOPMENTS 152

13.10.5 SWOT ANALYSIS 152

13.10.6 KEY STRATEGIES 152

14 APPENDIX 153

14.1 REFERENCES 153

14.2 RELATED REPORTS 153